Nicotine decreases agrin signaling and acetylcholine receptor clustering in C2C12 myotube culture.
The clustering of acetylcholine receptors (AChRs) in skeletal muscle fibers is a critical event in neuromuscular synaptogenesis. AChRs in concert with other molecules form postsynaptic scaffolds in response to agrin released from motor neurons as motor neurons near skeletal muscle fibers in development. Agrin drives an intracellular signaling pathway that precedes AChR clustering and includes the tyrosine phosphorylation of AChRs. In C2C12 myotube culture, agrin application stimulates the agrin signaling pathway and AChR clustering. Previous studies have determined that the frequency of spontaneous AChR clustering is decreased and AChRs are partially inactivated when bound by the acetylcholine agonist nicotine. We hypothesized that nicotine interferes with AChR clustering and consequent postsynaptic scaffold formation. In the present study, C2C12 myoblasts were cultured with growth medium to stimulate proliferation and then differentiation medium to stimulate fusion into myotubes. They were bathed in a physiologically relevant concentration of nicotine and then subject to agrin treatment after myotube formation. Our results demonstrate that nicotine decreases agrin-induced tyrosine phosphorylation of AChRs and decreases the frequency of spontaneous as well as agrin-induced AChR clustering. We conclude that nicotine interferes with postsynaptic scaffold formation by preventing the tyrosine phosphorylation of AChRs, an agrin signaling event that precedes AChR clustering.
Ferayorni
Angelique J
AJ
Department of Anatomy, Arizona College of Osteopathic Medicine, Midwestern University, Glendale, 85308, USA.
Gunville
Cameron F
CF
Grow
Wade A
WA
D018171:Agrin / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D008856:Microscopy, Fluorescence; D018482:Muscle, Skeletal / Q000187:drug effects / Q000502:physiology*; D009469:Neuromuscular Junction / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D009538:Nicotine / Q000494:pharmacology*; D010766:Phosphorylation; D051381:Rats; D011940:Receptor Aggregation / Q000187:drug effects / Q000502:physiology; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D013569:Synapses / Q000187:drug effects / Q000378:metabolism
D018171:Agrin; D005731:Ganglionic Stimulants; D011978:Receptors, Nicotinic; D009538:Nicotine